Persistent Swelling After Facial Squamous Cell Carcinoma Excision
The persistent mild swelling 18 days post-excision most likely represents normal postoperative edema, but you must rule out residual/recurrent tumor, surgical site infection (despite antibiotic treatment), hematoma/seroma formation, or a pathergy-like reaction with eruptive squamous cell carcinoma.
Most Critical Differential: Residual or Recurrent Disease
- Incomplete excision of facial SCC occurs in 6-8% of cases, with head and neck locations being the highest risk site for positive margins 1, 2
- The cheek is a particularly high-risk location, with incomplete excision rates significantly elevated in facial locations including cheeks, ears, temples, and nose 2
- Facial SCCs require histologically confirmed negative margins of at least 4-6 mm for high-risk tumors, and inadequate margins are strongly associated with local recurrence 3
- If margins were not confirmed histologically as negative, residual tumor must be considered as the cause of persistent swelling 3
Rare but Critical: Eruptive Post-Operative SCC (Pathergy-Like Reaction)
- Eruptive SCCs can develop within healing surgical sites as early as 6 weeks post-excision, presenting as rapidly growing keratotic nodules even when original margins were histologically clear 4
- This pathergy-like reaction represents a rare but significant postoperative complication where new SCCs develop acutely in wound margins 4
- At 18 days post-op, this is on the early end but within the timeframe for this phenomenon 4
Infection Considerations
- While flucloxacillin was given for 13 days, persistent swelling after appropriate antibiotic therapy suggests either inadequate source control, resistant organism, or non-infectious etiology 5
- True bacterial infection would typically show progressive erythema, warmth, purulent drainage, or systemic signs—not isolated mild swelling 5
- If infection is suspected, consider imaging (ultrasound or MRI) to evaluate for abscess or fluid collection requiring drainage 3
Immediate Diagnostic Approach
Perform the following evaluation now:
- Biopsy any clinically suspicious area of the wound or swelling immediately to rule out residual/recurrent SCC before proceeding with any further management 6
- Examine the original pathology report to confirm margin status—if margins were positive or close (<4 mm), residual tumor is highly likely 3
- Obtain ultrasound of the area to differentiate solid tissue (tumor) from fluid collection (seroma/hematoma/abscess) 3, 5
- Palpate regional lymph nodes (preauricular, submandibular, cervical) for metastatic disease, as facial SCCs have significant lymphatic spread potential 3
Management Algorithm Based on Findings
If biopsy shows residual/recurrent SCC:
- Re-excision with wider margins (minimum 6 mm for facial high-risk SCC) with intraoperative margin assessment 3
- Consider Mohs micrographic surgery for facial location to maximize tissue preservation while ensuring complete excision 3
- Do not perform complex reconstruction until negative margins are confirmed 6
If imaging shows fluid collection:
- Ultrasound-guided aspiration for diagnosis and potential therapeutic drainage 5
- Send aspirate for culture if infection is suspected, though routine culture is not indicated for simple seromas 5
If evaluation is negative for tumor and infection:
- Normal postoperative edema can persist for weeks, particularly in facial surgery 6
- Continue observation with close follow-up every 2-4 weeks 3
- Any change in character (firmness, nodularity, rapid growth) mandates immediate re-biopsy 4
Critical Pitfalls to Avoid
- Never assume persistent swelling is benign edema without histologic confirmation that original margins were adequate 3, 1
- Do not perform complex flap reconstruction or skin grafting until you have definitively ruled out residual tumor 6
- Facial SCC locations have the highest incomplete excision rates—always verify margin status 1, 2
- Be aware that well-differentiated SCCs can recur locally even with apparently adequate initial treatment 7, 8
- Document a specific follow-up plan with clear criteria for re-evaluation 5